Format

Send to

Choose Destination
See comment in PubMed Commons below
J Clin Microbiol. 2014 Feb;52(2):632-4. doi: 10.1128/JCM.02177-13. Epub 2013 Nov 20.

Impact of changes in Clostridium difficile testing practices on stool rejection policies and C. difficile positivity rates across multiple laboratories in the United States.

Author information

1
Atlanta Research and Education Foundation, Atlanta, Georgia, USA.

Abstract

We describe the adoption of nucleic acid amplification tests (NAAT) for Clostridium difficile diagnosis and their impact on stool rejection policies and C. difficile positivity rates. Of the laboratories with complete surveys, 51 (43%) reported using NAAT in 2011. Laboratories using NAAT had stricter rejection policies and increased positivity rates.

PMID:
24478500
PMCID:
PMC3911329
DOI:
10.1128/JCM.02177-13
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center